Daily Archives: 8th September 2022

News

Basilea enters into asset purchase agreement with Glioblastoma Foundation for oncology drug candidate

Basilea has entered into an asset purchase agreement with the Glioblastoma Foundation, for Basilea’s oncology drug candidate lisavanbulin (BAL101553), which has been developed as...

Sanofi and Biovac manufacturing partnership to produce polio vaccines in Africa

Sanofi and Biovac, a Cape Town, South Africa-based biopharmaceutical company, have announced a local manufacturing partnership to produce inactivated polio vaccines (IPV) in Africa. This...

European Commission grants Sobi Marketing Authorisation for ALTUVOCT for treatment of haemophilia A

The European Commission has granted Marketing Authorisation for Sobi's ALTUVOCT (efanesoctocog alfa), for the treatment and prevention of bleeds and perioperative prophylaxis in haemophilia...